Genmab Announces Financial Results for the First Quarter of 2024 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Novartis Pharma AG continues to build up its radiopharmaceutical powerhouse and has expanded a peptide discovery collaboration with Peptidream Inc. in a deal worth up to $2.71 billion. Under the multi-program agreement, Kawasaki, Japan-based Peptidream will use its peptide discovery platform system technology to identify and optimize novel macrocyclic peptides against targets selected by Novartis for potential conjugation to radioligand therapies or other applications for both therapeutic and diagnostic purposes.
Vigil Neuroscience (NASDAQ:VIGL – Get Free Report) and Amgen (NASDAQ:AMGN – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and valuation. Insider and Institutional Ownership 83.6% of Vigil Neuroscience shares […]
Amgen (NASDAQ:AMGN – Get Free Report) and Vigil Neuroscience (NASDAQ:VIGL – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and profitability. Analyst Ratings This is a breakdown of recent recommendations […]